NOTCH2 and Hyperglycemia: Notch2 is a target of miR-18a-5p which recently confirmed its antifibrotic role via the suppression of Notch2 and consequent inhibition of hyperglycemia-induced EndMT in human aortic valvular endothelial cells (HAVECs) (Geng and Guan, 2017).